SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2026

Completed Enrollment in LOTUS, a Phase 2b Trial of Zelicapavir in Pediatric Patients with Respirator

ENTA

Related stories